Properties (49)
Predicate | Object |
---|---|
gptkbp:instanceOf |
legal case
|
gptkbp:chargingTime |
fraud
|
gptkbp:class |
criminal trial
|
gptkbp:court |
gptkb:Ramesh_Balwani
gptkb:Elizabeth_Holmes gptkb:California gptkb:U.S._government 2021 2022 witness testimonies documentary evidence |
gptkbp:decidedBy |
gptkb:United_States_District_Court
|
https://www.w3.org/2000/01/rdf-schema#label |
United States v. Theranos
|
gptkbp:impact |
regulatory scrutiny
startup funding corporate fraud cases startup accountability cases healthcare_technology healthcare_fraud_cases |
gptkbp:involves |
gptkb:Theranos,_Inc.
gptkb:Elizabeth_Holmes |
gptkbp:jurisdiction |
federal court
|
gptkbp:legalStatus |
sentencing
corporate fraud accountability in startups healthcare_regulation |
gptkbp:mediaCoverage |
high-profile case
|
gptkbp:notable_player |
expert testimony
character witnesses |
gptkbp:notablePerson |
gptkb:Ramesh_Balwani
|
gptkbp:outcome |
guilty verdict
|
gptkbp:precedent |
consumer protection
corporate governance investor protection |
gptkbp:publicAccess |
controversial
media scrutiny investor backlash |
gptkbp:relatedPatent |
gptkb:United_States_v._Balwani
gptkb:United_States_v._Holmes gptkb:SEC_v._Theranos |
gptkbp:relatedTo |
investor fraud
patient safety issues blood testing technology |
gptkbp:research |
financial records
emails testimony from former employees |
gptkbp:tactics |
lack of intent
misleading statements |
gptkbp:yearEstablished |
2018
|